Search Within

Yao Yu

Formats
  1. Meeting Abstract (60)
  2. Journal Article (42)
  3. Book Section (3)
  4. Correspondence (3)
  5. Research Letter (3)
  6. Editorial (2)
  7. Review (2)
Groups
  1. Radiation Oncology, Department of (115)
  2. Solid Tumor Oncology Division (79)
  3. Department of Medicine (77)
  4. Head and Neck Service (65)
  5. Surgery (59)
  6. Survivorship Research (52)

More Groups

People
  1. Nancy Lee (89)
  2. Nadeem Riaz (67)
  3. Linda Chen (60)
  4. Sean McBride (60)
  5. Eric Sherman (59)
  6. Kaveh Zakeri (50)

More People

Years
  1. 2025 (9)
  2. 2024 (28)
  3. 2023 (13)
  4. 2022 (13)
  5. 2021 (17)
  6. 2020 (21)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (43)
  2. Journal of Clinical Oncology (14)
  3. Head & Neck (7)
  4. Neuro-Oncology (5)
  5. JAMA Oncology (4)
  6. Oral Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (53)
  2. American Society of Clinical Oncology (17)
  3. American Medical Association (7)
  4. John Wiley & Sons, Inc. (7)
  5. Oxford University Press (5)
  6. Wiley Blackwell (5)

More Publishers

Results (115)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact of co-alterations on outcomes after local therapy for patients with KRAS-mutant lung adenocarcinoma brain metastases
    Meeting Abstract

    Eichholz, J.; Gaeta, B.; Walch, H.; Boe, L.; Kratochvil, L.; del Balzo, L. A.; Yamada, Y.; Yu, Y.; Zinovoy, M.; Gomez, D. R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Symptomatic necrosis with antibody-drug conjugates and concurrent stereotactic radiotherapy for brain metastases
    Research Letter

    Lebow, E. S.; Pike, L. R. G.; Seidman, A. D.; Moss, N.; Beal, K.; Yu, Y.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Impact of surveillance imaging in patients with HPV-associated oropharyngeal carcinomas treated with definitive radiation and chemotherapy
    Meeting Abstract

    Shang, T.; Raab, G.; Chen, L.; Yu, Y.; Shamseddine, A.; Riaz, N.; McBride, S. M.; Gelblum, D.; Lee, N. Y.; Zakeri, K.
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer
    Journal Article

    Han, J.; Zakeri, K.; Raab, G.; Hesse, J.; Shamseddine, A.; Chen, L.; Yu, Y.; Kang, J. J.; McBride, S. M.; Riaz, N.; more...
    Head & Neck (2023)

    Fulltext@MSK | Save
  • Outcomes for organ preservation with chemoradiation therapy for T4 larynx and hypopharynx cancer
    Journal Article

    Eita, A.; Mohamed, N.; Rybkin, A.; Kang, J. J.; Fiasconaro, M.; Zhigang, Z.; Zakeri, K.; Yu, Y.; Sadaka, E.; Sherman, E.; more...
    Laryngoscope (2023)

    Fulltext@MSK | Save
  • Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity
    Journal Article

    Yu, Y.; Schòˆder, H.; Zakeri, K.; Chen, L.; Kang, J. J.; McBride, S. M.; Tsai, C. J.; Gelblum, D. Y.; Boyle, J. O.; Cracchiolo, J. R.; more...
    Oral Oncology (2023)

    Fulltext@MSK | Save
  • Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer
    Review

    Kang, J. J.; Yu, Y.; Chen, L.; Zakeri, K.; Gelblum, D. Y.; McBride, S. M.; Riaz, N.; Tsai, C. J.; Kriplani, A.; Hung, T. K. W.; more...
    CA - A Cancer Journal for Clinicians (2023)

    Fulltext@MSK | Save
  • Patient-reported outcomes (PROs) in cisplatin-ineligible patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) treated with enfortumab vedotin (EV) alone or in combination with pembrolizumab (P) in the phase 1b/2 EV-103 Cohort K study
    Meeting Abstract

    Milowsky, M. I.; O'Donnell, P. H.; Hoimes, C. J.; Petrylak, D. P.; Flaig, T. W.; Moon, H. H.; Friedlander, T. W.; Mar, N.; McKay, R. R.; Srinivas, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Enfortumab vedotin (EV) alone or in combination with pembrolizumab (P) in previously untreated cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer (la/mUC): Subgroup analyses of confirmed objective response rate (cORR) from EV-103 cohort K
    Meeting Abstract

    O'Donnell, P. H.; Rosenberg, J. E.; Hoimes, C. J.; Petrylak, D. P.; Milowsky, M. I.; McKay, R. R.; Srinivas, S.; Friedlander, T. W.; Ramamurthy, C.; Bilen, M. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Evaluation of proton therapy reirradiation for patients with recurrent head and neck squamous cell carcinoma
    Journal Article

    Lee, A.; Woods, R.; Mahfouz, A.; Kitpanit, S.; Cartano, O.; Mohamed, N.; Youssef, I.; Marqueen, K.; Sine, K.; Mah, D.; more...
    JAMA Network Open (2023)

    Fulltext@MSK | Save